ORTHOGEN GENTECHNOLOGIE GMBH has a total of 14 patent applications. Its first patent ever was published in 1994. It filed its patents most often in Germany, United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and medical technology are BAI TAO, FOURTH MILITARY MEDICAL UNIV and UNIV FUJITA HEALTH.
# | Country | Total Patents | |
---|---|---|---|
#1 | Germany | 4 | |
#2 | United States | 2 | |
#3 | WIPO (World Intellectual Property Organization) | 2 | |
#4 | Austria | 1 | |
#5 | Australia | 1 | |
#6 | Canada | 1 | |
#7 | Switzerland | 1 | |
#8 | EPO (European Patent Office) | 1 | |
#9 | Luxembourg | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Medical technology | |
#4 | Measurement |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Diagnosis and surgery | |
#5 | Syringes | |
#6 | Microbiology | |
#7 | Analysing materials | |
#8 | Measuring microorganism processes |
# | Name | Total Patents |
---|---|---|
#1 | Wehling Peter | 12 |
#2 | Reinecke Julio | 11 |
#3 | Meijer Hans | 10 |
#4 | Wehling Peter Dr Pd | 2 |
#5 | Reinecke Julio Dr | 2 |
#6 | Meijer Hans Dr | 2 |
#7 | Reincke Julio | 1 |
Publication | Filing date | Title |
---|---|---|
DE19903876A1 | Process for the in vitro formation and accumulation of interleukin-1 receptor antagonists | |
CH694074A5 | Process for the preparation of therapeutically active proteins. | |
EP0899271A1 | Process for inducing therapeutically active proteins | |
DE19753753A1 | New recombinant nucleic acid encoding proteins for modifying effects of cytokine systems, e.g. for treating infection or trauma | |
DE19500418A1 | Testing substances activity on, e.g. auto-immune and metabolic diseases | |
DE4444037A1 | Testing animal or human cells for gene defects |